Advexin (Ad5CMV-p53) combined with docetaxel (T) and doxorubicin (D) as induction chemotherapy (IC): significant efficacy of a novel gene-therapy approach for patients with locally advanced breast cancer (LABC).
BREAST CANCER RESEARCH AND TREATMENT(2004)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要